196 related articles for article (PubMed ID: 11354391)
21. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
[TBL] [Abstract][Full Text] [Related]
22. Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.
Landersdorfer CB; Kinzig M; Bulitta JB; Hennig FF; Holzgrabe U; Sörgel F; Gusinde J
Antimicrob Agents Chemother; 2009 Jun; 53(6):2569-78. PubMed ID: 19307356
[TBL] [Abstract][Full Text] [Related]
23. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
24. Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis.
Anon JB; Berkowitz E; Breton J; Twynholm M
Am J Otolaryngol; 2006; 27(4):248-54. PubMed ID: 16798401
[TBL] [Abstract][Full Text] [Related]
25. Overview of newer antimicrobial formulations for overcoming pneumococcal resistance.
Craig WA
Am J Med; 2004 Aug; 117 Suppl 3A():16S-22S. PubMed ID: 15360093
[TBL] [Abstract][Full Text] [Related]
26. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
27. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
Schaad UB; Casey PA; Cooper DL
Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form.
Hoffman A; Danenberg HD; Katzhendler I; Shuval R; Gilhar D; Friedman M
J Control Release; 1998 Jun; 54(1):29-37. PubMed ID: 9741901
[TBL] [Abstract][Full Text] [Related]
29. Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin and Synulox in healthy cats.
Vree TB; Dammers E; van Duuren E
ScientificWorldJournal; 2002 May; 2():1369-78. PubMed ID: 12805922
[TBL] [Abstract][Full Text] [Related]
30. Identical pattern of highly variable absorption of clavulanic acid from four different oral formulations of co-amoxiclav in healthy subjects.
Vree TB; Dammers E; Exler PS
J Antimicrob Chemother; 2003 Feb; 51(2):373-8. PubMed ID: 12562705
[TBL] [Abstract][Full Text] [Related]
31. Administration of ticarcillin in combination with clavulanic acid intravenously and intrauterinely to clinically normal oestrous mares.
Van Camp SD; Papich MG; Whitacre MD
J Vet Pharmacol Ther; 2000 Dec; 23(6):373-8. PubMed ID: 11168915
[TBL] [Abstract][Full Text] [Related]
32. Sinus tissue pharmacokinetics after oral administration of amoxicillin/clavulanic acid.
Dinis PB; Monteiro MC; Martins ML; Silva N; Gomes A
Laryngoscope; 2000 Jun; 110(6):1050-5. PubMed ID: 10852529
[TBL] [Abstract][Full Text] [Related]
33. Introduction: historical perspective and development of amoxicillin/clavulanate.
Geddes AM; Klugman KP; Rolinson GN
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S109-12. PubMed ID: 17900874
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of amoxicillin/clavulanic acid combination and of both drugs alone after intravenous administration to goats.
Escudero E; Carceles CM; Vicente S
Br Vet J; 1996 Sep; 152(5):551-9. PubMed ID: 8885465
[TBL] [Abstract][Full Text] [Related]
35. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
36. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.
Canafax DM; Yuan Z; Chonmaitree T; Deka K; Russlie HQ; Giebink GS
Pediatr Infect Dis J; 1998 Feb; 17(2):149-56. PubMed ID: 9493813
[TBL] [Abstract][Full Text] [Related]
37. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia.
Benninger MS
Expert Opin Pharmacother; 2003 Oct; 4(10):1839-46. PubMed ID: 14521493
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacokinetics of the diastereomers of arteether in healthy volunteers.
Sabarinath SN; Asthana OP; Puri SK; Srivastava K; Madhusudanan KP; Gupta RC
Clin Pharmacokinet; 2005; 44(11):1191-203. PubMed ID: 16231969
[TBL] [Abstract][Full Text] [Related]
39. [Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily].
Jehl F; Klossek JM; Peynegre R; Serrano E; Castillo L; Bobin S; Desprez D; Renault C; Neel V; Rouffiac E; Borie C
Presse Med; 2002 Oct; 31(34):1596-603. PubMed ID: 12426976
[TBL] [Abstract][Full Text] [Related]
40. A new amoxicillin/clavulanate therapeutic system: preparation, in vitro and pharmacokinetic evaluation.
Kerč J; Opara J
Int J Pharm; 2007 Apr; 335(1-2):106-113. PubMed ID: 17141985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
